By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Shares of GenMark Diagnostics and Myriad Genetics rose more than 20 percent each in October, to lead the 34 stocks that comprise the GenomeWeb Daily News Index.

Overall, the Index gained 5 percent — less than the Nasdaq, which was up 6 percent for October, but outperforming the Nasdaq Biotech Index, which rose nearly 4 percent, and the Dow Jones Industrial Average, which gained 3 percent.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

British Nobel laureates and Fields Medal winners warn that a 'hard' Brexit could harm science across the UK, the Guardian reports.

Vox reports on inequities in genetic research and efforts to address them.

The New York Times reports that Arizona State University's Lawrence Krauss is retiring following allegations of sexual misconduct.

In PNAS this week: de novo NUS1 mutations linked to Parkinson's disease risk, candidate hepatocellular carcinoma drivers, and more.